Edmond de Rothschild (Suisse)’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2016 Q3	$2.24M	Buy	25,650 +800	+3%	+$69.8K	0.69%	30
2016 Q2	$2.14M	Buy	+24,850	New	+$2.14M	0.71%	36